| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 12/06/2001 | WO2001091805A2 Compounds for targeting endothelial cells |
| 12/06/2001 | WO2001091803A2 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 12/06/2001 | WO2001091802A1 Chimeric viral vectors for gene therapy |
| 12/06/2001 | WO2001091801A2 Methods of transducing neural cells using lentivirus vectors |
| 12/06/2001 | WO2001091799A2 Medicament for the treatment of immune reactions in the eye |
| 12/06/2001 | WO2001091793A1 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 12/06/2001 | WO2001091787A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
| 12/06/2001 | WO2001091739A2 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers |
| 12/06/2001 | WO2001091728A2 Nanoemulsion formulations |
| 12/06/2001 | WO2001091725A2 Biologically useful polyphosphates |
| 12/06/2001 | WO2001091699A2 Compositions and methods for identifying agents which modulate pten function and pi-3 kinase pathways |
| 12/06/2001 | WO2001091548A2 Mice heterozygous for wfs1 gene as mouse models for depression |
| 12/06/2001 | WO2001091536A2 Genetic vaccine that mimics natural viral infection and induces long-lasting immunity to pathogens |
| 12/06/2001 | WO2001068805A8 Human olfactory receptors and genes encoding same |
| 12/06/2001 | WO2001064922A3 Heterologous expression of neisserial proteins |
| 12/06/2001 | WO2001059141A3 Methods and compositions that utilize barley as a foodstuff for animals |
| 12/06/2001 | WO2001057271A8 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human breast and bt 474 cells |
| 12/06/2001 | WO2001057216A3 Method for the production of a protein |
| 12/06/2001 | WO2001055387A8 Nucleic acids, proteins, and antibodies |
| 12/06/2001 | WO2001055313A8 Nucleic acids, proteins, and antibodies |
| 12/06/2001 | WO2001053351A3 Apoptin bindendes protein |
| 12/06/2001 | WO2001053323A3 Plants tolerant of environmental stress conditions, methods of generating same and novel polynucleotide sequence utilized thereby |
| 12/06/2001 | WO2001051644A3 ANTI-CD3 SINGLE-CHAIN ANTIBODIES HAVING HUMAN Cν3 AND Cν4 DOMAINS |
| 12/06/2001 | WO2001049717A3 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or t cell subset activity by modulation of xbp-1 activity |
| 12/06/2001 | WO2001048240A3 Implication of a known gene named cp2/lsf-lbp-1 in alzheimer's desease |
| 12/06/2001 | WO2001048180A3 Method and apparatus for targeting localised electroporation |
| 12/06/2001 | WO2001046686A3 Chromatography material and a method using same |
| 12/06/2001 | WO2001046392A3 Homologues of human heparanase and splice variants thereof |
| 12/06/2001 | WO2001046224A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 12/06/2001 | WO2001042421A3 Long-term cell culture compositions and genetically modified animals derived therefrom |
| 12/06/2001 | WO2001040273A3 Transgenic zebra fish embryo model for hematopoiesis and lymphoproliferative disorders |
| 12/06/2001 | WO2001036670A3 Diagnosis kit, method and microarray for determining human detoxification capacity |
| 12/06/2001 | WO2001036669A3 Method for the controlled implementation of complex pcr amplifications |
| 12/06/2001 | WO2001034647A3 Animal collagens and gelatins |
| 12/06/2001 | WO2001034646A3 Recombinant gelatins |
| 12/06/2001 | WO2001034130A9 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| 12/06/2001 | WO2001032897A3 A high level, stable, constitutive promoter element for plants |
| 12/06/2001 | WO2001032879A3 Method for producing recombinant interleucin-8 and interleucin-8 muteins |
| 12/06/2001 | WO2001032864A3 Gpcr-kd5 polypeptides and dna sequences thereof |
| 12/06/2001 | WO2001030854A3 Antibody to human gastrointestinal epithelial tumor antigen related to alpha 6 beta 4 integrin |
| 12/06/2001 | WO2001030381A3 Use of csf-1 inhibitors |
| 12/06/2001 | WO2001027630A3 Methods to identify compounds that modulate neuronal activity |
| 12/06/2001 | WO2001027150A3 Anthozoa derived chromo/fluoroproteins and methods for using the same |
| 12/06/2001 | WO2001023607A3 Multiplex pcr for detecting ehec infections |
| 12/06/2001 | WO2001023594A3 Enhanced stress tolerance in maize via manipulation of cell cycle regulatory genes |
| 12/06/2001 | WO2001023553A9 Metastasis-associated antigen c4.4a |
| 12/06/2001 | WO2001023421B1 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 12/06/2001 | WO2001023401A3 Use of codon-varied oligonucleotide synthesis for synthetic sequence recombination |
| 12/06/2001 | WO2001022922A3 Engineering antibodies that bind irreversibly |
| 12/06/2001 | WO2001020035A3 Methods and compositions for linear isothermal amplification of polynucleotide sequences |
| 12/06/2001 | WO2001018217A3 Thermus promoters for gene expression |
| 12/06/2001 | WO2001018042A3 Apoptosis proteins |
| 12/06/2001 | WO2001016345A3 Sequence-specific dna recombination in eukaryotic cells |
| 12/06/2001 | WO2001016307A3 Plant promoter sequences from maize for selective control of gene expression |
| 12/06/2001 | WO2001014540A3 Starch synthase isoform v |
| 12/06/2001 | WO2001014416A3 Synthetic papillomavirus genes optimized for expression in human cells |
| 12/06/2001 | WO2001012775A8 25 human secreted proteins |
| 12/06/2001 | WO2001012662A3 Membrane associated proteins |
| 12/06/2001 | WO2001011075A3 Pcr-based detection and quantification of tapesia yallundae and tapesia acuformis |
| 12/06/2001 | WO2001005432A3 Conjugate for mediating cell, compartment or membrane-specific transport of active substances |
| 12/06/2001 | WO2000077233A3 Complement-resistant non-mammalian dna viruses and uses thereof |
| 12/06/2001 | WO2000077206A3 The myostatin gene promoter and inhibition of activation thereof |
| 12/06/2001 | WO2000063427A3 Compound screening method |
| 12/06/2001 | WO2000061750A3 TYROSINE KINASE SUBSTRATE (Tks) PROTEINS |
| 12/06/2001 | WO2000038517A9 Methods for reducing adverse side effects associated with cellular transplantation |
| 12/06/2001 | WO2000025804A9 A method for inhibition of phospholamban activity for the treatment of cardiac disease and heart failure |
| 12/06/2001 | WO2000011166A9 14274 receptor, a g-protein coupled receptor related to the edg receptor family |
| 12/06/2001 | WO1997017448A3 Calcium independent cytosolic phospholipase a2/b enzymes |
| 12/06/2001 | US20010049834 A polynucleotide sequence comprising the cDNA insert which encodes a polypeptide with PR1-C10 like activity; genetic engineerig |
| 12/06/2001 | US20010049833 A DNA sequences which are able to inhibit proteins required for cell function, or which control senescence or germination and/or which control protein metabolism, in particular of stored protein |
| 12/06/2001 | US20010049832 Introducing into plant cell a recombinant expression cassette comprising a root transcriptional factor polynucleotide operably linked to a promoter, culturing the plant cell, inducing expression of polynuceotide to code the polypeptide |
| 12/06/2001 | US20010049831 Contacting a plant cell with a vector containing a nucleic acid sequence comprising a structural gene encoding FT polypeptide, operably associated with a promoter, to obtain transformed plant cell, producing plant from transformed cell |
| 12/06/2001 | US20010049830 Molecular farming |
| 12/06/2001 | US20010049829 Developmental competence for assisted reproduction and nuclear transfer in pigs |
| 12/06/2001 | US20010049438 Purification of primer extension products |
| 12/06/2001 | US20010049437 Electrophoretic separation of nucleic acids from proteins at low ph |
| 12/06/2001 | US20010049436 Presence of one or more POPS block; especially an inverted hybrid oligonucleotide. |
| 12/06/2001 | US20010049435 Myostatin gene promoter and inhibition of activation thereof |
| 12/06/2001 | US20010049360 Betaglycan as an inhibin receptor and uses thereof |
| 12/06/2001 | US20010049358 DSP-12 and DSP-13 dual-specificity phosphatases |
| 12/06/2001 | US20010049145 Hepatitis B virus vectors for gene therapy |
| 12/06/2001 | US20010049144 Genetically engineering a primate for expression of a desired gene, comprising introducing into the primate a transgene of a Rous Sarcoma Virus promoter (RSV) and a nucleic acid sequence heterologous to said RSV promoter; gene therapy |
| 12/06/2001 | US20010049142 A rapid, simple-to-use method to differentiate nondividing cells by fusing two different cells and then purifying them without antibiotic or metabolic selection; kits with two nontoxic dyes and instructions; antitumor agents |
| 12/06/2001 | US20010049137 DNA fragments derived from the genomic DNA of HPV-33, including recombinant vectors, which cells are replicated in host cells and expressed as immunogenic proteins; diagnosis of tumors; antibodies to detect viral infections |
| 12/06/2001 | US20010049136 Deletion of: all or part of the E1A regions, the E1B region coding for the early proteins, E2 or E4 regions, the E1a region and encapsidation region; gene therapy |
| 12/06/2001 | US20010049133 Method of protein removal |
| 12/06/2001 | US20010049129 Containing a recombinant plasmid pVIC40 and deposited on Nov. 19, 1987 in the collection of microorganism cultures at the USSR Antibiotics Rearch Institute under Reg. No. 1867; efficiency; nutrients; feeds; drugs |
| 12/06/2001 | US20010049126 Escherichia constructed from a sucrose non-assimilative strain, harboring sucrose-6-phosphotransferase system (sucrose PTS) genes that can produce an amino acid other than threonine; using sucrose as carbon source improves yield |
| 12/06/2001 | US20010049125 Amplifying a target nucleotide, involving generating concatemers formed by polymerase chain reaction (PCR) amplification of overlapping fragments; kit comprising a bivalent primer and instructions |
| 12/06/2001 | US20010049123 Nucleotide sequences encoding the dapC gene and process for the production of L-lysine |
| 12/06/2001 | US20010049122 For reducing inflammation, for treating an autoimmune disease, for enhancing transplantation of tissue grafts, increasing antitumor immunity, and inhibiting viral and parasitic infections |
| 12/06/2001 | US20010049121 Polypeptides and polynucleotides; drug screening, use in therapy, diagnostic assays |
| 12/06/2001 | US20010049120 Expression vector for consistent cellular expression of the tet on repressor in multiple cell types |
| 12/06/2001 | US20010049109 Comprising a donor dye having a specified absorption maxima, and an acceptor dye capable of absorbing excitation energy emitted by the donor dye and emitting light in response of given emission maxima |
| 12/06/2001 | US20010049108 Methods for reducing non-specific binding to an oligonucleotide array |
| 12/06/2001 | US20010049107 Patient-specific library of antineoplastic antibodies or fragments; variable regions are linked, cloned into expression vectors, amplified; libraries transferred to other expression vectors without losing diversity |
| 12/06/2001 | US20010049106 ADAM (A Disintegrin And Metalloprotease) family of metalloproteases, and in addition contain thrombospondin domain (TS); treating diabetes, arthritis, cancer, solid tumors, autoimmune diseases |
| 12/06/2001 | US20010049105 Electrophoretic tag (e-tag) probes; detection involves the release of identifying tags as a consequence of target recognition |
| 12/06/2001 | US20010049104 Methods for modulating cellular and organismal phenotypes |
| 12/06/2001 | US20010049094 Accurate isolation, detection |